Some insurers require: Prior authorization Step therapy failure BMI documentation For cost-saving strategies, see: How to Save on Prescription Drugs 2026 Access & Global Distribution As demand grows globally, regulated prescription fulfillment and compliant logistics are critical
That 10 to 15 minutes at room temperature, repeated every dose for weeks, adds up to hours of unnecessary heat exposure
The evidence-based starting dose is 0.25mg subcutaneously daily for 3 days, escalating to 0.5mg daily for 710 days during the loading phase
Cani is a research associate from the FRS-FNRS (Fonds de la Recherche Scientifique) and a recipient of grants from the FNRS and PDR (projet de recherche, Belgium) and ARC (Concerted Research ActivitiesFrench Community of Belgium convention: 12/17-047)
Novo Nordisk, maker of the glucagon-like peptide-1 (GLP-1) agonist medication semaglutide (Wegovy), recently received accelerated approval from the U.S